Article
<i>WEScover</i> : selection of whole exome sequencing vs. gene panel testing
2018-07-27
Abstract excerpt
<h4>Motivation</h4> Whole exome sequencing (WES) is widely adopted in clinical and research settings. However, there is potential for false negatives due to incomplete breadth and depth of coverage for several exons in clinically implicated genes. In some cases, a targeted gene panel testing may be a dependable option to ascertain true negatives for genomic variants in known phenotype associated genes. We develop...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5b0e1c4c-a442-58a5-a0f0-c4541089b00d
- DOI
- 10.1101/367607
